EASL Podcasts
By European Association for the Study of the Liver
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 153
Description
The EASL Podcast collection brings together Talk Liver to Me, EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues.
Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.
| Episode | Date |
|---|---|
|
Talk Liver To Me - Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment?
|
Jun 10, 2026 |
|
Talk Liver To Me - Liver Transplantation: Rise of the machines
|
May 13, 2026 |
|
Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules?
|
Apr 29, 2026 |
|
EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)
|
Apr 23, 2026 |
|
Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible
|
Apr 15, 2026 |
|
EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies
|
Apr 09, 2026 |
|
EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
|
Apr 09, 2026 |
|
EASL DeepDive: Key Changes in the New EASL HBV Guidelines
|
Apr 09, 2026 |
|
Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss
|
Apr 01, 2026 |
|
Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care?
|
Mar 18, 2026 |
|
Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease
|
Mar 04, 2026 |
|
Talk Liver To Me - MetALD in Practice: Does it Change How We Treat Patients?
|
Feb 18, 2026 |
|
Talk Liver To Me - From imposter syndrome to influence: Women shaping hepatology
|
Feb 04, 2026 |
|
Talk Liver To Me - Hepatology Ward Rounds: East Meets West
|
Jan 21, 2026 |
|
EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC
|
Dec 18, 2025 |
|
EASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?
|
Dec 11, 2025 |
|
EASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology
|
Dec 04, 2025 |
|
EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
|
Nov 27, 2025 |
|
EASL Studio Podcast: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports?
|
Nov 13, 2025 |
|
EASL Studio Podcast: Are we finally entering an era of effective treatment for PSC?
|
Nov 06, 2025 |
|
EASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?
|
Oct 09, 2025 |
|
EASL Studio Podcast: The Clinical Blind Spot: Are We Neglecting Alcohol?
|
Oct 02, 2025 |
|
EASL Studio Podcast: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?
|
Sep 25, 2025 |
|
EASL Studio Podcast: What Matters Most? The questions every hepatologist should ask their patients
|
Sep 18, 2025 |
|
EASL DeepDive: Diagnosis, non-invasive screening and risk stratification of MASLD cases
|
Jun 27, 2025 |
|
EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?
|
Jun 19, 2025 |
|
EASL DeepDive: MASLD Cirrhosis: Addressing unmet needs and defining valuable endpoints
|
Jun 13, 2025 |
|
EASL Studio Podcast: Steatotic Liver Disease Unpacked: Targeting Dynamic Risks
|
Jun 12, 2025 |
|
EASL Studio Podcast: Artificial Intelligence: Is This the Beginning of the End of the Medical Profession as We Know It?
|
Jun 05, 2025 |
|
EASL Studio Podcast: Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment Guidelines
|
May 29, 2025 |
|
EASL Studio Podcast: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice
|
May 22, 2025 |
|
EASL/CIRSE Studio Podcast: Interventional radiology in hepatology: Building bridges to optimise care
|
May 20, 2025 |
|
EASL Studio Podcast: Beyond the myths: Alcohol harm and policy action
|
May 20, 2025 |
|
EASL Studio Podcast: Screening strategies for liver fibrosis
|
May 20, 2025 |
|
EASL Studio Podcast: Landmark studies at EASL Congress 2025
|
May 20, 2025 |
|
EASL DeepDive: Key for TIPS Success: Identifying Suitable Candidates and Risk Control
|
May 15, 2025 |
|
EASL Studio Podcast: Endoscopic Management of Variceal Bleeding: Outdated or Evolving Beyond Tradition?
|
Apr 10, 2025 |
|
EASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?
|
Apr 04, 2025 |
|
EASL DeepDive: Understanding and managing PBC symptoms
|
Apr 04, 2025 |
|
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency
|
Apr 04, 2025 |
|
EASL DeepDive: What is the future of PBC treatment?
|
Apr 04, 2025 |
|
EASL Studio Podcast: JHEP Live: JHEP at 40: What to Expect Next?
|
Apr 03, 2025 |
|
EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions
|
Mar 27, 2025 |
|
EASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related Harm
|
Mar 20, 2025 |
|
EASL Studio Podcast: Understanding Sex Disparities in MASLD
|
Mar 13, 2025 |
|
EASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s Disease
|
Mar 06, 2025 |
|
EASL Studio Podcast: Liver Cancer Care in 2025: Progress, Hope, and What Lies Ahead
|
Feb 27, 2025 |
|
EASL Studio Podcast: YI choice: From Idea to Abstract to Publication: Navigating Your Research journey
|
Feb 20, 2025 |
|
EASL Studio Podcast: JHEP Live – EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?
|
Feb 13, 2025 |
|
EASL Studio Podcast: 2025 Update on Steatotic Liver Disease: Rethinking Standard of Care
|
Feb 06, 2025 |
|
EASL Studio Podcast: The liver as a master regulator of ageing, health, and longevity
|
Dec 12, 2024 |
|
EASL Studio Podcast: TIPS: How far can we go?
|
Dec 05, 2024 |
|
EASL Studio Podcast: Sarcopenia: Converting research findings into clinical practice - Are we doing enough?
|
Nov 28, 2024 |
|
EASL Studio Podcast: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies
|
Nov 21, 2024 |
|
EASL Studio Podcast: What’s hot and not in liver transplantation: EASL CPG 2024 update
|
Nov 14, 2024 |
|
EASL Studio Podcast: Why does WHO engagement with Steatotic Liver Disease matter?
|
Oct 03, 2024 |
|
EASL Studio Podcast: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?
|
Sep 26, 2024 |
|
EASL Studio Podcast: Are we relearning how to manage renal dysfunction in cirrhosis?
|
Sep 05, 2024 |
|
EASL Studio Podcast: Buongiorno Milano: What not to miss during EASL Congress
|
Jun 12, 2024 |
|
EASL Studio Podcast: Advances in systemic treatments in liver cancer
|
Jun 12, 2024 |
|
EASL Studio Podcast: Exploring new frontiers: The AI liver taskforce initiative
|
Jun 12, 2024 |
|
EASL Studio Podcast: SLD nomenclature: Need for refinement?
|
Jun 12, 2024 |
|
EASL Studio Podcast: Landmark studies at the EASL Congress 2024
|
Jun 12, 2024 |
|
EASL Studio Podcast: Education at the heart of EASL’s mission
|
Jun 12, 2024 |
|
EASL Studio Podcast: Arrivederci Milano, hallo Amsterdam!
|
Jun 12, 2024 |
|
EASL Studio Podcast: What‘s hot in viral hepatitis in 2024?
|
May 30, 2024 |
|
EASL Studio Podcast: Endohepatology: The endoscopic liver gold rush
|
May 23, 2024 |
|
EASL Studio Podcast: Resmetirom: First approved drug for MASH, for whom and for how long?
|
May 16, 2024 |
|
EASL Studio Podcast: Do we care enough about the importance of DILI/DHILI ?
|
May 10, 2024 |
|
EASL Studio Podcast: Assessment of clinically significant portal hypertension in 2024 – Is it time to say goodbye to invasive measurements?
|
May 02, 2024 |
|
EASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatology
|
Mar 28, 2024 |
|
EASL Studio Podcast: Therapy hierarchy in HCC: A new kid on the block
|
Mar 21, 2024 |
|
EASL Studio Podcast: Is there a role for measuring blood ammonia in patients with cirrhosis?
|
Mar 14, 2024 |
|
EASL Studio Podcast: The impact of policy measure in preventing liver diseases: The Hepahealth II study
|
Mar 07, 2024 |
|
EASL Studio Podcast: Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapy
|
Feb 29, 2024 |
|
EASL Studio Podcast: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis?
|
Feb 22, 2024 |
|
EASL Studio Podcast: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond
|
Feb 15, 2024 |
|
EASL Studio Podcast: How to stop recurrent bleeding due to small-intestinal angiodysplasia?
|
Feb 08, 2024 |
|
EASL Studio Podcast: Do we solve MASLD by treating obesity?
|
Jan 25, 2024 |
|
EASL Studio Podcast: EASL Studio’s holiday reflection: A look back to leap forward
|
Dec 21, 2023 |
|
EASL Studio Podcast: Hepatic encephalopathy: Underdiagnosed and underestimated
|
Dec 14, 2023 |
|
EASL Studio Podcast: Basics in decision-making for liver cancer treatment
|
Dec 07, 2023 |
|
EASL Studio Podcast: PSC and AIH overlap syndrome: does it actually exist?
|
Nov 30, 2023 |
|
EASL Studio Podcast: The window hypothesis again, or just a closed window?
|
Nov 23, 2023 |
|
EASL Studio Podcast: Why should diabetologists care about the liver?
|
Nov 16, 2023 |
|
EASL Studio Podcast: Alcohol and the new nomenclature – A game-changer?
|
Nov 09, 2023 |
|
JHEP Live: Hepatitis delta’s latest debate: Updates straight from EASL’s slate
|
Nov 02, 2023 |
|
EASL Studio Podcast: Why bother with diet and exercise when an injection will suffice?
|
Oct 19, 2023 |
|
EASL Studio Podcast: YI Choice: When stars fade: The untold story of burnout in academia
|
Oct 12, 2023 |
|
EASL Studio Podcast: JHEP Live: The new nomenclature for SLD: A multidisciplinary evaluation and approach
|
Oct 05, 2023 |
|
EASL Studio Podcast: Highlights from the EASL SLD Summit 2023
|
Sep 27, 2023 |
|
EASL Studio Podcast: Zoonotic Hepatitis E – What’s hot in 2023?
|
Sep 21, 2023 |
|
EASL Studio Podcast: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways
|
Sep 14, 2023 |
|
EASL Studio Podcast: What is really new in the EASL CPG on ACLF?
|
Sep 07, 2023 |
|
EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease
|
Aug 18, 2023 |
|
EASL Studio Podcast: Practice changing highlights from EASL Congress 2023
|
Aug 17, 2023 |
|
EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature
|
Aug 17, 2023 |
|
EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy
|
Aug 17, 2023 |
|
EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023
|
Aug 17, 2023 |
|
EASL Studio Podcast: EASL Congress 2023: Back to the future
|
Aug 17, 2023 |
|
EASL Studio Podcast: The conundrum of NASH: The growing global disease burden with low disease awareness
|
Jun 15, 2023 |
|
EASL Studio Podcast: JHEP Live: New and promising drugs for NASH on the horizon
|
Jun 08, 2023 |
|
EASL Studio Podcast: Why you should stop smoking if you love your liver
|
Jun 01, 2023 |
|
EASL Studio Podcast: COST Actions: Opportunities for pan-European collaborations in liver diseases
|
May 25, 2023 |
|
EASL Studio Podcast: Promoting Liver Health: An urgent call for action at WHO
|
May 24, 2023 |
|
EASL Studio Podcast: HDV: The devil becomes treatable
|
May 19, 2023 |
|
EASL Studio Podcast: Liver nurses in Europe: Are there enough and can they do more?
|
May 11, 2023 |
|
EASL Studio Podcast: Albumin in cirrhosis: For all, for some, for none
|
May 04, 2023 |
|
EASL Studio Podcast: Highlights from the EASL Liver Cancer Summit 2023
|
Apr 27, 2023 |
|
EASL Studio Podcast: Diagnostic and therapeutic challenges in Wilson’s disease
|
Apr 20, 2023 |
|
EASL Studio Podcast: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance
|
Apr 19, 2023 |
|
EASL Studio Podcast: EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure
|
Apr 13, 2023 |
|
EASL Studio Podcast: JHEP Live: Liver transplantation for alcohol-related hepatitis
|
Apr 06, 2023 |
|
EASL Studio Podcast: NAFLD and NASH – moving beyond the liver biopsy – where are we now?
|
Mar 30, 2023 |
|
EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond
|
Mar 23, 2023 |
|
EASL Studio Podcast: Ascites: New solution for an old problem?
|
Mar 16, 2023 |
|
EASL Studio Podcast: YI Choice: Gender equality in academics — reducing the gap
|
Mar 09, 2023 |
|
EASL Studio Podcast: Alcohol and food policies
|
Mar 02, 2023 |
|
EASL Studio Podcast: Regenerating the liver graft with a machine?
|
Feb 16, 2023 |
|
EASL Studio Podcast: AI for Dummies
|
Feb 09, 2023 |
|
EASL Studio Podcast: JHEP Live: Is the term ‘decompensated cirrhosis’ outdated?
|
Feb 02, 2023 |
|
EASL Studio Podcast: A 360 approach to beat alcohol-related liver disease
|
Jan 26, 2023 |
|
EASL Studio Podcast: YI Choice: How to build consortia and registries
|
Jan 19, 2023 |
|
EASL Studio Podcast: Hepatitis B elimination: How far behind are we and what do we need to change to achieve it?
|
Jan 12, 2023 |
|
EASL Studio Podcast: Liver cancer in 2022: Wrap-up & outlook
|
Dec 22, 2022 |
|
EASL Studio Podcast: Chronic portal vein thrombosis: Anticoagulation and interventional radiology for all patients?
|
Dec 15, 2022 |
|
EASL Studio Podcast: The future of hepatology
|
Dec 08, 2022 |
|
EASL Studio Podcast: Next-generation metrics for science beyond Journal impact factor and citations: The role of social media
|
Dec 01, 2022 |
|
EASL Studio Podcast: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within
|
Nov 24, 2022 |
|
EASL Studio Podcast: Regenerative Hepatology: From stem cells to tissue engineering
|
Nov 17, 2022 |
|
EASL Studio Podcast: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?
|
Nov 03, 2022 |
|
EASL Studio Podcast: Transplanting patients with cancer – Is there a limit?
|
Oct 31, 2022 |
|
EASL Studio Podcast: Bugs and the liver — The role of the gut microbiome in liver diseases
|
Oct 20, 2022 |
|
EASL Studio Podcast: How to improve end-of-life care in liver disease?
|
Oct 13, 2022 |
|
EASL Studio Podcast: JHEP Live: Stigma and alcohol
|
Oct 06, 2022 |
|
EASL Studio Podcast: Special Edition: Highlights of EASL NAFLD Summit 2022
|
Sep 29, 2022 |
|
EASL Studio Podcast: Liver transplantation for ACLF: Opportunities, challenges and pitfalls
|
Sep 15, 2022 |
|
EASL Studio Podcast: JHEP Live: Covid vaccination and associated autoimmune hepatitis
|
Sep 09, 2022 |
|
EASL Studio Podcast: Teatime - 23 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Teatime - 25 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Teatime - 24 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Teatime - 22 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Midday Talks on Improving Liver Cancer Care and Prevention - 23 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: How can our response to the climate crisis transform and improve hepatology services?
|
Jun 30, 2022 |
|
EASL Studio Podcast: EASL Haemochromatosis Guidelines 2022
|
Jun 16, 2022 |
|
EASL Studio Podcast: JHEP Live on the best animal model for HCC – Lost in translation?
|
Jun 02, 2022 |
|
EASL Studio Podcast : Digital Pathology
|
May 20, 2022 |
|
EASL Studio Podcast: Nurse and AHP Focus: Sustainable Hepatology – Insights in nursing initiatives
|
May 11, 2022 |
|
EASL Studio Podcast - YI Choice: Propelling liver cell biology into the third dimension
|
Apr 21, 2022 |
|
EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?
|
Apr 05, 2022 |
|
EASL Studio Podcast: New era for science dissemination: The role of social media
|
Apr 05, 2022 |
|
EASL Studio Podcast: Should anticoagulants be given to patients with cirrhosis to improve outcome?
|
Apr 05, 2022 |
|
Liver Cancer
|
Mar 24, 2021 |